
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CRISP-1 CRISPR/Cas9 KO Plasmid (m) | sc-419035 | 20 µg | $397.00 |
Crisp1 encodes cysteine-rich secretory protein 1 (CRISP-1), a member of the CAP (cysteine-rich secretory proteins/antigen 5/pathogenesis-related 1) superfamily that is highly expressed in the male reproductive tract and secreted into the epididymal lumen. In mouse, CRISP-1 associates with sperm during epididymal maturation and contributes to gamete interactions, including regulation of sperm capacitation and participation in sperm–zona pellucida binding and fertilization-related events. At the cellular level, CRISP-1 is linked to secretory pathway biology and extracellular protein interactions that modulate membrane and signaling properties of spermatozoa. Dysregulation of Crisp1 is relevant to studies of male fertility phenotypes and reproductive tract function, and it is also used as a model for CAP-family protein roles in mucosal and immune-related contexts.
CRISP-1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Crisp1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Crisp1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Crisp1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CRISP-1 protein expression.
This CRISPR knockout system enables efficient generation of Crisp1-deficient cell models for investigation of CRISP-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.